- Home
- RZLT vs MCR Comparison
RZLT vs MCR Comparison
Compare RZLT & MCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RZLT
- MCR
- Stock Information
- Founded
- RZLT 2010
- MCR 1989
- Country
- RZLT United States
- MCR United States
- Employees
- RZLT N/A
- MCR N/A
- Industry
- RZLT Biotechnology: Pharmaceutical Preparations
- MCR Trusts Except Educational Religious and Charitable
- Sector
- RZLT Health Care
- MCR Finance
- Exchange
- RZLT Nasdaq
- MCR Nasdaq
- Market Cap
- RZLT 226.4M
- MCR 266.0M
- IPO Year
- RZLT N/A
- MCR N/A
- Fundamental
- Price
- RZLT $2.89
- MCR $6.31
- Analyst Decision
- RZLT Strong Buy
- MCR
- Analyst Count
- RZLT 8
- MCR 0
- Target Price
- RZLT $12.00
- MCR N/A
- AVG Volume (30 Days)
- RZLT 569.6K
- MCR 66.7K
- Earning Date
- RZLT 05-14-2025
- MCR 01-01-0001
- Dividend Yield
- RZLT N/A
- MCR 8.52%
- EPS Growth
- RZLT N/A
- MCR N/A
- EPS
- RZLT N/A
- MCR 0.38
- Revenue
- RZLT N/A
- MCR N/A
- Revenue This Year
- RZLT N/A
- MCR N/A
- Revenue Next Year
- RZLT N/A
- MCR N/A
- P/E Ratio
- RZLT N/A
- MCR $16.61
- Revenue Growth
- RZLT N/A
- MCR N/A
- 52 Week Low
- RZLT $1.89
- MCR $5.63
- 52 Week High
- RZLT $6.19
- MCR $6.70
- Technical
- Relative Strength Index (RSI)
- RZLT 22.31
- MCR 45.07
- Support Level
- RZLT $3.25
- MCR $6.21
- Resistance Level
- RZLT $3.30
- MCR $6.32
- Average True Range (ATR)
- RZLT 0.23
- MCR 0.05
- MACD
- RZLT -0.05
- MCR 0.00
- Stochastic Oscillator
- RZLT 10.40
- MCR 72.67
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income. The fund invests the assets in debt instruments. It invests the assets in corporate bonds of U.S. and foreign issuers, U.S. Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S. and foreign issuers, and debt instruments of issuers located in emerging market countries.